Home  
Advanced Search  
Product of DHCC
Clinicians
Veterans
Family and Friends
Reserve Resources
Deployment Cycle Support
Guidelines
Emerging Health Concerns
News and announcements
Library
Education and Training
Risk Communications
Research
War on Terrorism
Are You a New User?
About DHCC
Contact DHCC
Index and Site Map
Help and FAQs
508-Compliant Site

Mefloquine/Lariam®


Policies and Directives

DoD / Joint Forces

Army

Navy / Marines

VA (Veterans Administration)

Back to topBack to Top

Clinical Guidance

  • FDA Mefloquine Medication Label, Aug 03


  • FDA Mefloquine (Lariam®) Medication Guide, Sep 03


  • FDA 2003 Safety Alert - Lariam


  • Mefloquine (Lariam®) Information for Clinicians, 9 Dec 03


  • Back to topBack to Top

    Fact Sheets

  • Mefloquine (Lariam®) Information for Unit Leaders, 12 Apr 04


  • Mefloquine (Lariam®) Information for Military Service Members and Their Families, 12 Apr 04


  • FDA Mefloquine (Lariam®) Medication Guide, Sep 03


  • USACHPPM Deployment Medication Information - Mefloquine Tablets (Anti-Malarial Medication), Feb 04


  • USACHPPM Lariam Pocket Card, Aug 03


  • Back to topBack to Top

    Other Related Information

  • MedlinePlus - Mefloquine


  • Malaria Page


  • Back to topBack to Top

    Research

  • The Risk of Severe Depression, Psychosis or Panic Attacks with Prophylactic Antimalarials, Drug Safety 2004; 27 (3): 203-213


  • Tolerability of Malaria Chemoprophylaxis in Non-immune Travelers to Sub-Saharan Africa: Multicentre, Randomised, Double Blind, Four Arm Study; BMJ Vol 327, 8 Nov 03


  • Back to topBack to Top

    Related Links

  • Lariam.com


  • CDC Travelers' Health - Malaria


  • Back to topBack to Top


     
     
     
     
     
     Browser Information Security & Privacy Notice